An
implantable
bioartificial kidney is similar to existing
extracorporeal renal assist device (RAD), which is a bioartificial
kidney that combines a membrane hemofilter and a bioreactor to
function as a healthy kidney. However, to work as a natural kidney,
the bioartificial kidney should have high efficiency ultrafiltration
membranes, should be able to regulate blood flow, and stabilize
necessary cells. Implantable bioartificial kidney is capable of
replicating the work of real kidney and can eliminate the need for
dialysis. Implantable bioartificial kidney avoids constant physician
oversight and need to take immunosuppressant drugs and medication.
Get
In-Depth Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/2339
Implantable
Bioartificial Kidney Market: Drivers
Increasing
number of chronic kidney disease patients, rising number of kidney
failure incidences, and long waiting list for kidney transplants is
expected to boost the global implantable bioartificial kidney market
growth over the forecast period. For instance, according to Kidney
Health Australia, 2010, the cost of treating all current and new
cases of End Stage Kidney Disease (ESKD) will reach up to US$ 12
billion by 2020. Moreover, according to the Centers for Disease
Control & Prevention (CDC), around 15% of the adults in the U.S.
were estimated to have chronic kidney disease in 2017. CDC states
that around 96% of the people with kidney damage or hampered kidney
function are not aware of having chronic kidney disease. These
factors are expected to drive the global implantable bioartificial
kidney market growth over the forecast period.
Individual
government organizations and manufacturers are working towards
increasing the awareness of kidney diseases. For instance, American
Kidney Fund (AKF) launched a comprehensive new kidney disease
education portal in May 2018. The education portal called as ‘CKD
Central’ will provide information and resources on chronic kidney
disease (CKD). Moreover, The Kidney Project is a national research
project, which aims to create a small, surgically implanted, and
free-standing bioartificial kidney to treat end stage renal disease
(ESRD). This kidney is expected to provide ESRD patients with a new
option beyond the short-term solution of renal dialysis and the
costly kidney transplant for which donor organs are limited.
Implantable
Bioartificial Kidney Market: Regional Analysis
North
America implantable bioartificial kidney market is expected to hold
dominant position in the global market over the forecast period.
According to the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), over 661,000 people in the U.S. had kidney
failure and of these, 468,000 individuals were on dialysis, in 2017.
The kidney project, headed by researchers from the University of
California San Francisco (UCSF), the University of Vanderbilt, and
the National Institute of Biomedical Imaging and Bioengineering
(NIBIB), is expected to receive approval for the artificial kidney
trials by late 2018 or early 2019. These factors are expected to
support the North America implantable bioartificial kidney market
growth over the forecast period. According to report of Brazilian
Transplant Registry, 2016, Brazil accounts for the second largest
number of kidney transplant programs in the world.
Implantable
Bioartificial Kidney Market: Taxonomy
The
global implantable bioartificial kidney market is segmented on the
basis of end user, and region.
By
End User: Hospitals, Organ Transplant Centers, Others
By
Region: North America, Latin America, Europe, Asia Pacific,
Middle East, Africa
Request
For Customization of This Business Report @
https://www.coherentmarketinsights.com/insight/request-customization/2339
Also,
Coherent Market Insights has a proprietary database of pipeline
biologics and biosimilars, called PHASE-XS. This database provides
analytical data in addition to the clinical information of ongoing
trials for biologics and biosimilars. An amalgamation of more than 30
parameters, PHASE-XS helps biotechnology and pharmaceutical companies
to analyze the market trend, competition, and market potential. For
more information or to access this database, kindly click on the
below link or contact at sales@coherentmarketinsights.com
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment